Effects of azilsartan compared to other angiotensin receptor blockers on left ventricular hypertrophy and the sympathetic nervous system in hemodialysis patients

Effects of azilsartan compared to other angiotensin receptor blockers on left ventricular hypertrophy and the sympathetic nervous system in hemodialysis patients - Effects of azilsartan compared to other angiotensin receptor blockers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011845

Enrollment

Registered

2013-09-24

Start date

2012-10-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

17 hypertensive patients on hemodialysis, who had been administrated ARBs, except for azilsartan, and after enrollment they were switched to azilsartan. We evaluated at baseline and at the 6-month fol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypertensive patients on hemodialysis who had been administrated ARBs except azilsartan for more than 6 months before enrolling this study.

Exclusion criteria

Exclusion criteria: Atrial fibrillation, poor adherence to medication, poor fluid restriction and hospitalization upon enrolling study

Design outcomes

Primary

Measure	Time frame
ambulatory blood pressure monitoring, cardiac funcion evaluated by echocardiography and serum noradrenaline at the 6-month follow-up.	—

Countries

Japan

Contacts

Public ContactTakanori Kusuyama

Tsukazaki Hospital Cardiology

takanori.kusuyama@nifty.ne.jp+81-79-272-8555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026